Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

ClinicalTrials.gov ID: NCT01153009

Public ClinicalTrials.gov record NCT01153009. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Duloxetine-Referenced, Fixed-Dose Study Comparing the Efficacy and Safety of 2 Doses (15 and 20 mg) of Lu AA21004 in Acute Treatment of Adults With Major Depressive Disorder

Study identification

NCT ID
NCT01153009
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
614 participants

Conditions and interventions

Interventions

  • Vortioxetine Drug
  • Duloxetine Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2010
Primary completion
Feb 29, 2012
Completion
Feb 29, 2012
Last update posted
Dec 17, 2013

2010 – 2012

United States locations

U.S. sites
56
U.S. states
24
U.S. cities
56
Facility City State ZIP Site status
Not listed Beverly Hills California
Not listed Chino California
Not listed Garden Grove California
Not listed Irvine California
Not listed Los Alamitos California
Not listed Oceanside California
Not listed Pasadena California
Not listed Pico Rivera California
Not listed San Diego California
Not listed Colorado Springs Colorado
Not listed Norwalk Connecticut
Not listed Boca Raton Florida
Not listed Fort Myers Florida
Not listed Gainesville Florida
Not listed Jacksonville Florida
Not listed Lauderhill Florida
Not listed Orlando Florida
Not listed Tampa Florida
Not listed West Palm Beach Florida
Not listed Atlanta Georgia
Not listed Marietta Georgia
Not listed Chicago Illinois
Not listed Libertyville Illinois
Not listed Oakbrook Ter Illinois
Not listed Valparaiso Indiana
Not listed Shreveport Louisiana
Not listed Boston Massachusetts
Not listed Weymouth Massachusetts
Not listed Rochester Hills Michigan
Not listed Flowood Mississippi
Not listed Toms River New Jersey
Not listed Cedarhurst New York
Not listed Fresh Meadows New York
Not listed New York New York
Not listed Rochester New York
Not listed Staten Island New York
Not listed Cincinnati Ohio
Not listed Toledo Ohio
Not listed Oklahoma City Oklahoma
Not listed Portland Oregon
Not listed Allentown Pennsylvania
Not listed Media Pennsylvania
Not listed Philadelphia Pennsylvania
Not listed North Charleston South Carolina
Not listed Memphis Tennessee
Not listed Nashville Tennessee
Not listed Austin Texas
Not listed Dallas Texas
Not listed Houston Texas
Not listed Irving Texas
Not listed San Antonio Texas
Not listed Orem Utah
Not listed Woodstock Vermont
Not listed Richmond Virginia
Not listed Middleton Wisconsin
Not listed Waukesha Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01153009, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 17, 2013 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01153009 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →